Skip to content

Effects of Rock Climbing on Parkinson's Disease

Effects of Rock Climbing on Parkinson's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05919771
Enrollment
32
Registered
2023-06-26
Start date
2023-07-12
Completion date
2024-08-12
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking & mobility, hand strength & dexterity, and psychological well-being in individuals with Parkinson's Disease (PD). The rock climbing sessions are administered and supervised by Up ENDing Parkinson's, and are tailored to the skill level of the participant. Participants will answer questionnaires and complete physical performance tests twice, first prior to beginning the sessions and then again after the 24 sessions have been completed.

Detailed description

Parkinson's disease (PD) compromises multiple systems (neurological, musculoskeletal, cardiopulmonary, cognitive) over time, leading to functional decline. Additionally, individuals with PD may experience stressors commonly associated with chronic illness that can negatively impact psychological well-being. Exercise is commonly prescribed for individuals with PD and recently, interventions that are vigorous in nature and community- and performance-based are gaining traction (e.g., dancing, boxing, rock climbing). Despite increasing popularity, the evidence-base for these programs is still developing and far from conclusive. Recommendations are strong for: Community-based exercise, intensive aerobic and resistance training, and external cueing (Osborne et al., 2022). Rock climbing (RC) contains each of these elements and could potentially be a therapeutic intervention for people with PD. Yet little is known about the outcomes of this particular form of organized physical activity programs for this health condition. One such program is the rock climbing experiences offered by the UpENDing Parkinson's Rock Climbing (UEPRC). The specific aims of this study are to characterize the effects of UEPRC on: 1) mobility and walking; 2) upper extremity (UE) functioning and 3) psychological and social well-being. Participants will complete 24 rock climbing sessions tailored to their skill levels supervised by UEPRC over approximately 12 weeks.

Interventions

OTHERrock climbing

Vertical ascent of a surface specifically designed to elicit the skills that might be required to scale a naturally occurring rock formation

Sponsors

Marymount University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 18 years old * Diagnosis of Parkinson's disease * Hoehn & Yahr score 1-3 * able to speak and read in English; * able to ambulate at least 10 meters with no assistive device or human assistance

Exclusion criteria

* neurological disease diagnosis other than PD; * uncontrolled cardiovascular, pulmonary, neurological, or metabolic disease which may impact the ability to exercise or in which exercise is contraindicated; * cognitive or psychiatric impairment precluding informed consent or ability to following instructions; * pregnancy; * inability to ambulate 10 meters without assistive device or human assistance

Design outcomes

Primary

MeasureTime frameDescription
Change in Community Mobility and AmbulationBaseline and at 12 weeksTest of specific tasks to be accomplished to walk forward on a level surface safely and efficiently as evidence by the Community Balance and Mobility Scale (CBMS). CBMS is scored from 0-96 with higher scores denoting better performance.

Secondary

MeasureTime frameDescription
Change in AgilityBaseline and at 12 weeksTest of the ability to move forward, laterally, and backward on a level surface safely and efficiently as evidence by the Agility T-Test.
Change in DexterityBaseline and at 12 weeksThis test assesses upper extremity dexterity by assessing the time it takes to remove 9 pegs from a tray and place in peg holes and then remove pegs and place them back in tray as measured by the 9-Hole Peg Test.
Change in Reaction TimeBaseline and at 12 weeksThis test assesses combined cognitive and physical reaction time to initiate a movement response utilizing colored light stimuli as evidenced by using Blaze Pods.
Change in ResilienceBaseline and at 12 weeksThis survey measures one's ability to thrive in the face of adversity as evidenced by the Connor-Davidson Resilience Scale 25 (CD-RISC-25). CD-RISC-25 scores range from 0-100 with higher scores indicating greater resilience.
Change in Social AdaptationBaseline and at 12 weeksThis survey measures motivation and behavior as related to work and hobbies, family and relationships, and social situations as evidenced by the Social Adaptation Self-Evaluation Scale (SAS). SAS scores range from 0-63 with higher scores representing better social adaptation.
Change in ApathyBaseline and at 12 weeksThis survey addresses lack of emotion, interest, concern, or recognition of goals by measuring levels of participant's interest, motivation, and engagement as evidenced by the Starkstein Apathy Scale. The Starkstein Apathy Scale scores range from 0-42 with higher scores representing greater levels of apathy.

Other

MeasureTime frameDescription
Change in Grip strengthBaseline and at 12 weeksMeasure of force production in the dominant hand using a hand-held dynamometer. The score is force output in pounds, with higher force output representing greater strength.
Change in Quality of Life across Multiple Dimensions: Perception of difficulty with daily life across 8 dimensions of daily livingBaseline and at 12 weeksThis survey is a multidimensional survey covering mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort as evidenced by the Parkinson's Disease Questionnaire-39 (PDQ-39). PDQ-39 provides scores from 0-100 in each of the 8 domains listed and an overall Summary Index score from 0-100. Lower scores reflect better quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026